This notice has been superseded. See the latest notice: Structured Product Labeling (SPL) HT9426-26-Q-E022 (Combined Synopsis/Solicitation)
Combined Synopsis/SolicitationActivePANDHA-26-P-0000035401
Structured Product Labeling (SPL)
DEPT OF DEFENSE / DEFENSE HEALTH AGENCY (DHA) / ARMY MED RES ACQ ACTIVITYKey dates?
- Posted?
- May 15, 2026
- Response deadline?
- Jun 5, 2026, 6:00 PM UTC
- Archive date?
- —
- Archive type?
- auto15
Classification?
- Notice type?
- Combined Synopsis/Solicitation
- Base type?
- Combined Synopsis/Solicitation
- Set-aside?
- No Set aside used
- Set-aside code?
- NONE
- PSC?
- R408
NAICS?
Issuing office?
- Department?
- DEPT OF DEFENSE
- Sub-tier?
- DEFENSE HEALTH AGENCY (DHA)
- Office?
- ARMY MED RES ACQ ACTIVITY
- Office code?
- 097.97DH.HT9425
- Organization type?
- OFFICE
- Office address?
- FORT DETRICK, MD, 21702, USA
Place of performance?
- Street?
- —
- Street 2?
- —
- City?
- Frederick
- State?
- Maryland
- Zip?
- 21702
- Country?
- UNITED STATES
Contacts?
- Matthew Gembeprimary
- Terrie Bloom, Contracting Officersecondary
Description?
Office of Regulated Activities of the DHA R&D – Medical Research and Development Command (MRDC) has a requirement to manage, process, and complete initial labeling and labeling changes in electronic structured product label document submissions to the FDA. Structured Product Labeling (SPL) is a Health Level Seven (HL7) standard based on Clinical Document Architecture and HL7 Reference Information Model (RIM) accredited by the American National Standards Institute (ANSI) for the exchange of product information. The DHA R&D – MRDC currently has 2 licensed New Drug Application (NDA) products which require SPL submissions for up to 5 levels of primary and secondary labeling.
Attachments (6)?
- Download📎 Performance+Work+Statement+-+ORA+SPL+Requirement.docxapplication/octet-stream · 30 KB
- Download📎 B08+Attachment+4+-+Pricing+Sheet+SPL+Requirement.xlsxapplication/octet-stream · 12 KB
- Download📎 B08+Attachment+1+-+Non-Disclosure+Agreement.docxapplication/octet-stream · 15 KB
- Download📎 B08+Attachment+2+-+Organizational+Conflict+of+Interest+Certification+Form.docxapplication/octet-stream · 22 KB
- Download📎 B08.+Solicitation+-+HT942626QE022.pdfapplication/pdf · 12.9 MB
- Download📎 B08+Attachment+3+-+Past+Performance+References.pdfapplication/pdf · 145 KB
Other notices in this solicitation?
- Combined Synopsis/SolicitationStructured Product Labeling (SPL) HT9426-26-Q-E022Jun 29, 2026LATEST
- Combined Synopsis/SolicitationStructured Product Labeling (SPL) HT9426-26-Q-E022Jun 23, 2026LATEST
- Combined Synopsis/SolicitationStructured Product Labeling (SPL) HT9426-26-Q-E022Jun 10, 2026
- Combined Synopsis/SolicitationStructured Product Labeling (SPL) HT9426-26-Q-E022Jun 5, 2026
- Combined Synopsis/SolicitationStructured Product Labeling (SPL) HT9426-26-Q-E022May 20, 2026
Similar open contracts
Metadata?
- Notice ID?
- 49b8a3965c784a5daf77fc960ba60c16
- Full path?
- DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).ARMY MED RES ACQ ACTIVITY
- Office code?
- 097.97DH.HT9425
- Ingested?
- May 16, 2026
- Updated?
- Jul 11, 2026